Our study on SFRP2 in human breast cancer leads to the following conclusions: SFRP2 expression is very frequently downregulated in breast cancer due to promoter methylation, thus conferring growth advantage to neoplastic mammary cells. The gene discussed is SFRP2; the disease is breast cancer.